iRay Group (SHA:688301)
71.27
+1.55 (2.22%)
Nov 17, 2026, 3:00 PM CST
iRay Group Revenue
iRay Group had revenue of 829.41M CNY in the quarter ending September 30, 2026, with 71.92% growth. This brings the company's total for the last twelve months to 3.20B, up 58.18% year-over-year. In the year 2025, iRay Group had annual revenue of 2.25B with 22.90% growth. That makes iRay Group the 11,516th largest company in the world by revenue and 1,945th in China.
Revenue (ttm)
3.20B
Revenue Growth
+58.18%
P/S Ratio
6.97
Revenue / Employee
1.40M
Employees
2,411
Market Cap
22.33B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full iRay Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.25B | 419.34M | 22.90% |
| Dec 31, 2024 | 1.83B | -32.39M | -1.74% |
| Dec 31, 2023 | 1.86B | 314.67M | 20.31% |
| Dec 31, 2022 | 1.55B | 361.76M | 30.47% |
| Dec 31, 2021 | 1.19B | 403.27M | 51.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Intco Medical Technology | 13.12B |
| Winner Medical | 11.25B |
| Tofflon Science and Technology Group | 5.15B |
| Zhende Medical | 4.65B |
| Gan & Lee Pharmaceuticals. | 4.37B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.32B |
| Imeik Technology Development | 2.33B |
| Autek China | 1.82B |